Key facts
- This page summarizes Tadataka Yamada's Form 3 filing for Icosavax, Inc..
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 28 Jul 2021, 21:23.
Tadataka Yamada - 28 Jul 2021 Form 3 Insider Report for Icosavax, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 28 Jul 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 28 Jul 2021, 21:23:49 UTC
- Prior SEC filing
- 01 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas Russo, Attorney-in Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Tadataka Yamada filed Form 3 for Icosavax, Inc. on 28 Jul 2021.
Change
- Previous filing in this sequence was filed on 01 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ICVX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 124,097
- Date
- 28 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
ICVX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 627,229
- Date
- 28 Jul 2021
- Ownership
- By Leslie D. Yamada 2016 Trust
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ICVX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 65,748
- Exercise price
- $1.04
- Footnotes
- F4
ICVX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 481,266
- Exercise price
- $5.90
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Includes 64,884 shares subject to repurchase by us, which are subject to vesting.
Footnote F2
Includes 53,280 shares subject to repurchase by us, which are subject to vesting.
Footnote F3
The securities reported herein may be deemed beneficially owned by Tadataka Yamada, M.D., who is a co-trustees of the Leslie D. Yamada 2016 Trust.
Footnote F4
25% of the shares subject to the option will vest on 1/14/2022, and 1/48th of the shares subject to the option vest monthly thereafter.
Footnote F5
25% of the shares subject to the option will vest on 3/19/2022, and 1/48th of the shares subject to the option vest monthly thereafter.
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney